Luminex Blog | Clinical Diagnostics and Life Sciences

Posted on July 28, 2020 by Christina Olivas

Luminex develops a number of instruments and molecular diagnostic tests that have to be reviewed by regulatory agencies before becoming commercially available. Each of them requires clinical trials to demonstrate accuracy and utility. For this, we count on team members like Eva Oleksy, Senior Clinical Research Associate. She joined Luminex in 2009, and holds a […]

Precision Coupling with Molar Amounts of Protein

Posted on July 15, 2020 (July 20, 2020) by Stephen Angeloni

Precision coupling is useful for multiplex antibody assays, screening recombinant antibodies, and more! I’ve been getting a lot of requests lately to provide more information on the molar coupling method. If you’ve been wondering how it works, here’s a quick look at how to incorporate molar coupling into your assay development. When coupling whole immunoglobulins […]

The Versatility of Multiplex Antibody Titer Assays for COVID-19 and Beyond

Posted on July 8, 2020 (June 10, 2020) by Stephen Angeloni

The COVID-19 outbreak that began in Wuhan, China in December 2019 was marked by an increase in the number of cases showing pneumonia-like symptoms.1,2 It was not until about a month after the outbreak began that genomic analysis identified a novel coronavirus as the causative agent. With the emergence of new pathogen strains, genomic assays […]

xMAP® Connect Virtual Conference – Inspiring Multiplexing Innovation

Posted on June 24, 2020 (June 10, 2020) by Hilary Graham

Luminex is proud to announce the xMAP® Connect Virtual Conference, hosted online this year by LabRoots. The goal of this conference is to connect fellow xMAP enthusiasts and provide best practices for multiplex assays, virtually from anywhere in the world. Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single […]

In Germany, Screening for COVID-19 with the ARIES® System

Posted on June 16, 2020 (June 15, 2020) by Sherry Dunbar, PhD

Clinical lab scientist describes his experience establishing a two-step diagnostic algorithm for COVID-19 Scientists in clinical labs worldwide have worked night and day in the COVID-19 pandemic to develop, validate, and implement new diagnostic tests for patients believed to be infected by the SARS-CoV-2 virus. While each lab’s experiences are slightly different, there are certain […]

Luminex’s Flexible SARS-CoV-2 Assays Enable Both High-Throughput and Emergency Testing

Posted on June 11, 2020 (June 18, 2020) by Sherry Dunbar, PhD

Federal funding and FDA Emergency Use Authorization streamlined development and commercialization of these new assays. As the COVID-19 pandemic swept across the globe, people everywhere have raced to respond. The Luminex team has been working around the clock on much-needed molecular diagnostic assays for the SARS-CoV-2 virus, two of which recently received Emergency Use Authorization […]

Questions to Ask When Choosing a Multiplex Assay Kit

Posted on June 5, 2020 (June 18, 2020) by Carrie Wittmer

With the COVID-19 pandemic in full swing, many researchers are looking to multiplex assays to evaluate what they call the “cytokine storm.” This refers to the increase in pro-inflammatory cytokines like IL-6 in patients with COVID-19, which is believed to predict disease severity.1 Many of Luminex’s Partners already have multiplex assays available for research use. […]

How Luminex Is Supporting Research Partners’ Pandemic Response

Posted on June 2, 2020 (June 18, 2020) by Hilary Graham

Licensed Technologies Group is finding new ways to boost partner programs Here at Luminex, we are working on all fronts to help fight the coronavirus pandemic. The most visible activities have been the launch of new diagnostic tests—namely, the NxTAG® CoV Extended Panel and the ARIES® SARS-CoV-2 Assay—both of which received Emergency Use Authorization from the […]

Considerations Regarding RNA Extraction Kits for SARS-CoV-2 Detection

Posted on May 21, 2020 (June 18, 2020) by Jackie Surls

The novel coronavirus disease (COVID-19) pandemic continues to trigger rapid development of molecular diagnostic tests around the world. Nucleic acid amplification-based tests (NAATs)—such as real-time PCR and isothermal amplification—are the gold standard in molecular diagnostic technologies that are being utilized to detect SARS-CoV-2, the COVID-19 disease-causing virus.1 There are two critical and sequential steps that […]

Webinar: Mouse Model Analysis Is Better with Multiplexing

Posted on May 13, 2020 (June 12, 2020) by Hilary Graham

Query hundreds of immunoassay targets, even with limited sample volume To make the most of immunology-focused assays using the limited tissue and fluid samples available from mouse models, scientists should consider using xMAP® Technology from Luminex, according to Daniel Braunschweig, Proteomics Field Application Scientist Leader at Bio-Rad Laboratories. That’s the takeaway from a 30-minute webinar […]

WordPress Download Manager